NewsEvents

Your Yourlocation: Home > Efficacy of tiotropium bromide(136310-93-5) inhalation in the treatment of chronic obstructive pulmonary disease

OBJECTIVE: To investigate the clinical efficacy of tiotropium bromide(136310-93-5) in the treatment of chronic obstructive pulmonary disease(COPD), and to summarize its clinical experience and clinical significance.

Methods: Sixty-four patients with stable chronic obstructive pulmonary disease (COPD) from November 2011 to November 2013 were randomly divided into observation group and control group according to the random extraction method. Each group was treated with tiotropium bromide(136310-93-5), the control group using conventional treatment, observation and comparison of the two groups of patients with the treatment effect, the incidence of adverse reactions, before and after treatment 2 weeks, 4 weeks, 8 weeks, 16 weeks, 24 weeks of FEV1 and FEV1 /FVC values.

Results: The total effective rate was 906% (29/32) in the observation group and 63% (2/32). The total effective rate was 68.8% (22/32) in the control group and the adverse reaction occurred the rate was 3.1% (1/32). There was significant difference between the two groups (P <0.05), which was statistically significant.

Conclusion: Tiotropium bromide(136310-93-5) in the treatment of chronic obstructive pulmonary disease in the clinical efficacy is significant, significantly better than the efficacy of conventional treatment advantage.

Address:211#Zhengfeng Building,Huanbaokejiyuan, Gaoxinkaifaqu, Jinan,250100,China TEL:086-531-82375818 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved